SS
This company develops a patented microneedle patch platform for painless, temperature-stable drug and vaccine delivery. The technology enables single-application, multi-dose delivery across human pharma, animal health, and nutraceutical markets. This system eliminates cold-chain requirements and simplifies administration for improved patient access and compliance.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company develops a patented microneedle patch platform for painless, temperature-stable drug and vaccine delivery. The technology enables single-application, multi-dose delivery across human pharma, animal health, and nutraceutical markets. This system eliminates cold-chain requirements and simplifies administration for improved patient access and compliance.